Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy
Jaroslav Žák(Scripps Research Institute), John R. Teijaro(Scripps Research Institute), Reza Beheshti Zavareh(Ontario Institute for Cancer Research), Isaraphorn Pratumchai(Scripps Research Institute), Kristi Marquardt(Scripps Research Institute), Luke L. Lairson(Scripps Research Institute), Veronika Bachanová(University of Minnesota), Michael B. A. Oldstone(Scripps Research Institute), Brett S. Marro(Scripps Research Institute), Judith A. Varner(University of California San Diego)
Cited by 6
Related Papers
Molecular mimicry and immune‐mediated diseases
|The FASEB Journal|1998|605
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
|Proceedings of the National Academy of Sciences|2012|594
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments.
|Proceedings of the National Academy of Sciences|1983|361
Integrin CD11b activation drives anti-tumor innate immunity
|Nature Communications|2018|313